Multimodality management of non-small cell lung cancer stage III: the pulmonologist as pilot and partner

A. Frille (Leipzig, Germany)

Source: Virtual Congress 2021 – Thoracic oncology
Session: Thoracic oncology
Session type: State of the art session
Number: 2980

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Frille (Leipzig, Germany). Multimodality management of non-small cell lung cancer stage III: the pulmonologist as pilot and partner. Virtual Congress 2021 – Thoracic oncology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
Source: Eur Respir Rev, 28 (152) 190024; 10.1183/16000617.0024-2019
Year: 2019



Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013



Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Radiotherapy with curative intent for stage I and II non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Source: ERS webinar 2021: Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Year: 2021


Management of stage I and II nonsmall cell lung cancer
Source: Eur Respir J 2017; 49(1): 1600764; DOI: 10.1183/13993003.00764-2016
Year: 2017




Impact of radiotherapy on outcomes of nivolumab in advanced non-small cell lung cancer: a case controlled study
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021


Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Source: Eur Respir Rev 2011; 20: 45-52
Year: 2011



Radiotherapy for stage III non-small cell lung cancer (NSCLC)
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I – IIIa nonsmall cell lung cancer conducted by the European lung cancer working party
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003

International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019
Year: 2020



The treatment of stage IV non-small cell lung cancer with target therapies
Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
Year: 2013


Imaging for staging stage III nonsmall cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=47
Year: 2007

Management of locally advanced nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 260–270
Year: 2009

The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Adjuvant chemotherapy in stage Ib of non-small cell lung cancer (NSCLC)-experience of a pneumology department
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

First- and second-line therapy for advanced nonsmall cell lung cancer
Source: Eur Respir J 2009; 33: 915-930
Year: 2009